Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Wegovy (semaglutide) received FDA accelerated approval to treat metabolic dysfunction-associated steatohepatitis (MASH), becoming the first GLP-1 therapy cleared for MASH in a patient population estimated at about 5% of U.S. adults, based
Techquake Weekend: Tariffs, Rocket Failures & a 1,000-Mile EV – Global Tech News Roundup (Aug 15–16, 2025)

Techquake Weekend: Tariffs, Rocket Failures & a 1,000-Mile EV – Global Tech News Roundup (Aug 15–16, 2025)

Consumer Technology Enterprise IT & Software Telecommunications Cybersecurity Automotive Technology Space Technology Semiconductors & Hardware Fintech & Crypto Biotechnology & Health Tech Robotics & Tech Culture Sources: Reuters, TechCrunch, FDA, FierceBiotech, company
1 120 121 122 123 124 159
Go toTop